Consensus Summary
Misfolded amyloid, tau, alpha-synuclein, TDP-43, FUS, or other aggregate-prone proteins seed toxicity and propagate between vulnerable circuits.
This consensus cluster currently contains 110 active SciDEX hypotheses with average composite score 0.5702. Disease coverage: cross_neurodegeneration: 85, PD: 4, protein biochemistry: 4, AD: 3, ALS: 3, protein folding: 3, multi: 2, unspecified: 2.
Cross-Disease Signal
Shared disease buckets represented here: AD, PD, ALS, FTD, cross_neurodegeneration. Clusters with AD/PD/ALS/FTD co-coverage are priority targets for transfer hypotheses, debate scheduling, and Forge validation tasks.
Top Hypotheses
-
SNCA conformer propagation across PD, DLB, and MSA (
h-cross-synth-snca-synucleinopathy): multi, score 0.82 -
MAPT tau seeding and release across AD, FTD, and PD-spectrum disease (
h-cross-synth-mapt-tau-seeding): multi, score 0.812 -
TIA1 Low-Complexity Domain Oxidation Drives Aberrant Stress Granule Assembly and TDP-43 Mislocalization in ALS Motor Neurons (
h-alsmnd-54f981ca6a25): ALS, score 0.81
Category Definition
Mechanism terms used for deterministic assignment: amyloid, abeta, a-beta, tau, mapt, synuclein, snca, tdp-43, tdp43, fus, prion, aggregate, misfold, seeding, phase separation, condensate.
Provenance
Generated by scripts/atlas_mechanism_consensus_map.py for Atlas task be26e8ca-f0cf-4a8d-b2ed-31a8e19e8c71 from the live PostgreSQL hypotheses table. Hypotheses are linked to the cluster node through knowledge_edges.relation='belongs_to_pathway_cluster'.
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.